Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells-Reference-Cited by-同舟云学术

Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells

Published:2021-12 Issue: Volume:101 Page:108288
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Fathi Mehrdad,Bahmanpour Simin,Barshidi Asal,Rasouli Hossein,Karoon Kiani Fariba,Mahmoud Salehi Khesht Armin,Izadi Sepideh,Rashidi Bentolhoda,Kermanpour Shiva,Mokhtarian Roya,Karpisheh Vahid,Hassannia Hadi,Mohammadi Hamed,Jalili Ali,Jadidi-Niaragh Farhad

Funder

NIMAD

Tabriz University of Medical Sciences

University of Kurdistan

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference39 articles.

1. Improving cancer immunotherapy by targeting the hypoxic tumor microenvironment: new opportunities and challenges;Noman;Cells,2019

2. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity;Zhang;Nat. Immunol.,2018

3. Targeting hypoxia-inducible factor-1, for cancer treatment: recent advances in developing small-molecule inhibitors from natural compounds;Ma;Semin. Cancer Biol.,2020